Menu

Know Labs, Inc. (KNW)

—
$2.14
+0.08 (3.88%)
Market Cap

N/A

P/E Ratio

N/A

Div Yield

0.00%

52W Range

$0.40 - $4.43

Company Profile

At a glance

• Know Labs (NYSE American: KNW) is developing proprietary non-invasive diagnostic technology utilizing radio and microwave spectroscopy, with a primary focus on a continuous blood glucose monitor (CGM) and a secondary strategy to license its extensive IP portfolio in other fields.

• Recent operational progress includes the development of the wearable KnowU (Generation 2) prototype, achieving promising early clinical study results with MARD figures around 11% compared to venous blood, and significantly expanding its global patent portfolio (>300 assets).

• The company faces significant financial challenges, including recurring losses, a net working capital deficit of $6.19 million as of March 31, 2025, and cash sufficient to operate only until June 30, 2025, raising substantial doubt about its ability to continue as a going concern.

Price Chart

Loading chart...

The most compelling investment themes are the ones nobody is talking about yet.

Every Monday, get three under-the-radar themes with catalysts, data, and stocks poised to benefit.

Sign up now to receive them!

Also explore our analysis on 5,000+ stocks